ALTIMMUNE, INC. Cash and Restricted Cash
ALTIMMUNE, INC. (ALT) had Cash and Restricted Cash of $63.05 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $63.05M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $97.64M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $43.80M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.28M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $63.05M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $97.64M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $43.80M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $61.28M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $183.15M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $49.15M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $36.97M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $31.52M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $57.17M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $79.02M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $135.16M 10-K · filed 2026-03-06 | |
| 2023-09-30 | $86.90M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $102.39M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $104.72M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $111.13M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $127.50M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $135.89M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $179.98M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $190.34M 10-K · filed 2024-03-27 | $190.33M 10-K · filed 2022-03-15 |
| 2021-09-30 | $174.90M 10-Q · filed 2022-11-10 | $174.90M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $174.14M 10-Q · filed 2022-08-11 | $174.14M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $149.97M 10-Q · filed 2022-05-12 | $149.97M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $115.95M 10-K · filed 2023-02-28 | $115.95M 10-K · filed 2021-02-25 |
| 2020-09-30 | $143.53M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $64.78M 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $11.31M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $9.00M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $11.01M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $41.71M 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $44.94M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $34.35M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $8.00M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $4.76M 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $8.09M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $12.30M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $17.15M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $8.40M 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $2.74M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $2.88M 10-K · filed 2019-04-01 | |
| 2016-09-30 | $5.10M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $5.13M 10-Q · filed 2017-08-14 | |
| 2015-12-31 | $4.64M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |